Vincent Lagente

Repeated endotoxin exposure induces interstitial fibrosis associated with enhanced gelatinase (MMP-2 and MMP-9) activity

V. Lagente, E. Boichot, B. Clement, 2001, Inflammation Research.

Influence of fatty acid ethanolamides and delta9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells.

V. Lagente, E. Boichot, N. Allain, 1997, European journal of pharmacology.

Pharmacological modulation of the bronchopulmonary action of the vasoactive peptide, endothelin, administered by aerosol in the guinea-pig.

P. Braquet, V. Lagente, J. Mencia-Huerta, 1989, Biochemical and biophysical research communications.

Endotoxin-induced acute lung injury in rats. Role of insulin.

V. Lagente, E. Boichot, Z. Fortes, 1999, Pulmonary pharmacology & therapeutics.

Regulation of IgE Production by β2‐Adrenoceptor Agonists

P. Braquet, V. Lagente, J. Mencia-Huerta, 1994 .

Effects of phosphodiesterase inhibitors and salbutamol on microvascular leakage in guinea-pig trachea.

S. Dahl, V. Lagente, J. Planquois, 1998, European journal of pharmacology.

Inhaled substance P induces activation of alveolar macrophages and increases airway responses in the guinea-pig

V. Lagente, E. Boichot, N. Frossard, 1993, Neuropeptides.

A tachykinin NK3 receptor antagonist, SR 142801 (osanetant), prevents substance P-induced bronchial hyperreactivity in guinea-pigs.

V. Lagente, C. Advenier, X. Emonds-alt, 1997, Pulmonary pharmacology & therapeutics.